Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner

Berberine and its derivatives display potent analgesic, anti-inflammatory and anticancer activity. Here we aimed at characterizing the mechanism of action of berberine in the gastrointestinal (GI) tract and cortical neurons using animal models and in vitro tests. The effect of berberine was characte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2015-12, Vol.10 (12), p.e0145556-e0145556
Hauptverfasser: Chen, Chunqiu, Lu, Meiling, Pan, Qiuhui, Fichna, Jakub, Zheng, Lijun, Wang, Kesheng, Yu, Zhen, Li, Yongyu, Li, Kun, Song, Aihong, Liu, Zhongchen, Song, Zhenshun, Kreis, Martin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0145556
container_issue 12
container_start_page e0145556
container_title PloS one
container_volume 10
creator Chen, Chunqiu
Lu, Meiling
Pan, Qiuhui
Fichna, Jakub
Zheng, Lijun
Wang, Kesheng
Yu, Zhen
Li, Yongyu
Li, Kun
Song, Aihong
Liu, Zhongchen
Song, Zhenshun
Kreis, Martin
description Berberine and its derivatives display potent analgesic, anti-inflammatory and anticancer activity. Here we aimed at characterizing the mechanism of action of berberine in the gastrointestinal (GI) tract and cortical neurons using animal models and in vitro tests. The effect of berberine was characterized in murine models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms. Then the opioid antagonists were used to identify the receptors involved. Furthermore, the effect of berberineon opioid receptors expression was established in the mouse intestine and rat fetal cortical neurons. In mouse models, berberine prolonged GI transit and time to diarrhea in a dose-dependent manner, and significantly reduced visceral pain. In physiological conditions the effects of berberine were mediated by mu- (MOR) and delta- (DOR) opioid receptors; hypermotility, excessive secretion and nociception were reversed by berberine through MOR and DOR-dependent action. We also found that berberine increased the expression of MOR and DOR in the mouse bowel and rat fetal cortical neurons. Berberine significantly improved IBS-D symptoms in animal models, possibly through mu- and delta- opioid receptors. Berberine may become a new drug candidate for the successful treatment of IBS-D in clinical conditions.
doi_str_mv 10.1371/journal.pone.0145556
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1751482452</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A438350498</galeid><doaj_id>oai_doaj_org_article_04aaf8540c4c46909ba64bfa6e7a3206</doaj_id><sourcerecordid>A438350498</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-3a8b9a5c18a6573e4a936d31a7773a8e0c21302974a7aea410087e4f147773463</originalsourceid><addsrcrecordid>eNqNk9tu1DAQhiMEolB4AwSWkFB7kcWOHSe5QeqBQ6RWrVrorTWbTHZdEjvY3kLfjYfDoduqi3qBEiXR-Jt_MqckecXojPGCvb-0K2egn43W4Iwykee5fJQ8YxXPUplR_vje91by3PtLSnNeSvk02cpkQWkps2fJ7310c3TaIKmH0dkr9KQ2AX3QUZwc26B7Ha4JmJZcaN-gi9ZT0IbEOywxEis_PVvsPTnWg26-a7MghxqcWyKkpw5bO0QxE0jtnA4w75Hs25_Yk_Nr0zo7INmp98_Tw91oGMZgBz-JgyEno7a6Tc-wwWh25BBHNC1GpWMwBt2L5EkHvceX6_d28u3Tx68HX9Kjk8_1wd5R2sgqCymHcl5B3rASZF5wFFBx2XIGRVHEM6RNxjjNqkJAAQiCxdoUKDomJkBIvp28udEde-vVuvBesSJnosxEnkWiviFaC5dqdHoAd60saPXXYN1CgQu66VFRAdCVuaCNaISsaDUHKeYdSCyAZ3SK9mEdbTUfsG1ivrHoG6KbJ0Yv1cJeKSHLSpQ0CuysBZz9sYqtVMPUub4Hg7Fb039neSloWUX07T_ow9mtqQXEBLTpbIzbTKJqT_CS51RUZaRmD1DxajFORZzSTkf7hsPuhkNkAv4KC1h5r-rzs_9nTy422Xf32DiEfVh626-CtsZvguIGbJz13mF3V2RG1bRkt9VQ05Kp9ZJFt9f3G3TndLtV_A-INiK7</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1751482452</pqid></control><display><type>article</type><title>Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Chen, Chunqiu ; Lu, Meiling ; Pan, Qiuhui ; Fichna, Jakub ; Zheng, Lijun ; Wang, Kesheng ; Yu, Zhen ; Li, Yongyu ; Li, Kun ; Song, Aihong ; Liu, Zhongchen ; Song, Zhenshun ; Kreis, Martin</creator><creatorcontrib>Chen, Chunqiu ; Lu, Meiling ; Pan, Qiuhui ; Fichna, Jakub ; Zheng, Lijun ; Wang, Kesheng ; Yu, Zhen ; Li, Yongyu ; Li, Kun ; Song, Aihong ; Liu, Zhongchen ; Song, Zhenshun ; Kreis, Martin</creatorcontrib><description>Berberine and its derivatives display potent analgesic, anti-inflammatory and anticancer activity. Here we aimed at characterizing the mechanism of action of berberine in the gastrointestinal (GI) tract and cortical neurons using animal models and in vitro tests. The effect of berberine was characterized in murine models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms. Then the opioid antagonists were used to identify the receptors involved. Furthermore, the effect of berberineon opioid receptors expression was established in the mouse intestine and rat fetal cortical neurons. In mouse models, berberine prolonged GI transit and time to diarrhea in a dose-dependent manner, and significantly reduced visceral pain. In physiological conditions the effects of berberine were mediated by mu- (MOR) and delta- (DOR) opioid receptors; hypermotility, excessive secretion and nociception were reversed by berberine through MOR and DOR-dependent action. We also found that berberine increased the expression of MOR and DOR in the mouse bowel and rat fetal cortical neurons. Berberine significantly improved IBS-D symptoms in animal models, possibly through mu- and delta- opioid receptors. Berberine may become a new drug candidate for the successful treatment of IBS-D in clinical conditions.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0145556</identifier><identifier>PMID: 26700862</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Analgesics ; Animal models ; Animals ; Anticancer properties ; Antidepressants ; Antitumor activity ; Berberine ; Berberine - pharmacology ; Care and treatment ; Diarrhea ; Diarrhea - complications ; Diarrhea - drug therapy ; Disease Models, Animal ; Female ; Fetuses ; Gastrointestinal Motility - drug effects ; Gastrointestinal tract ; Health aspects ; Hospitals ; In vitro methods and tests ; Inflammation ; Intestinal motility ; Intestine ; Irritable bowel syndrome ; Irritable Bowel Syndrome - complications ; Irritable Bowel Syndrome - drug therapy ; Laboratory animals ; Male ; Medical research ; Medicine ; Mice ; Mice, Inbred BALB C ; Mimicry ; Motility ; Narcotics ; Neurons ; Opioid receptors (type delta) ; Opioid receptors (type mu) ; Pain ; Pain perception ; Physiological effects ; Physiology ; Rats ; Rats, Sprague-Dawley ; Real-Time Polymerase Chain Reaction ; Receptors ; Receptors, Opioid - genetics ; Receptors, Opioid - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - genetics ; Rodents ; Secretion ; Visceral Pain - drug therapy ; Visceral Pain - etiology</subject><ispartof>PloS one, 2015-12, Vol.10 (12), p.e0145556-e0145556</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Chen et al 2015 Chen et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-3a8b9a5c18a6573e4a936d31a7773a8e0c21302974a7aea410087e4f147773463</citedby><cites>FETCH-LOGICAL-c692t-3a8b9a5c18a6573e4a936d31a7773a8e0c21302974a7aea410087e4f147773463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689480/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689480/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26700862$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Chunqiu</creatorcontrib><creatorcontrib>Lu, Meiling</creatorcontrib><creatorcontrib>Pan, Qiuhui</creatorcontrib><creatorcontrib>Fichna, Jakub</creatorcontrib><creatorcontrib>Zheng, Lijun</creatorcontrib><creatorcontrib>Wang, Kesheng</creatorcontrib><creatorcontrib>Yu, Zhen</creatorcontrib><creatorcontrib>Li, Yongyu</creatorcontrib><creatorcontrib>Li, Kun</creatorcontrib><creatorcontrib>Song, Aihong</creatorcontrib><creatorcontrib>Liu, Zhongchen</creatorcontrib><creatorcontrib>Song, Zhenshun</creatorcontrib><creatorcontrib>Kreis, Martin</creatorcontrib><title>Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Berberine and its derivatives display potent analgesic, anti-inflammatory and anticancer activity. Here we aimed at characterizing the mechanism of action of berberine in the gastrointestinal (GI) tract and cortical neurons using animal models and in vitro tests. The effect of berberine was characterized in murine models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms. Then the opioid antagonists were used to identify the receptors involved. Furthermore, the effect of berberineon opioid receptors expression was established in the mouse intestine and rat fetal cortical neurons. In mouse models, berberine prolonged GI transit and time to diarrhea in a dose-dependent manner, and significantly reduced visceral pain. In physiological conditions the effects of berberine were mediated by mu- (MOR) and delta- (DOR) opioid receptors; hypermotility, excessive secretion and nociception were reversed by berberine through MOR and DOR-dependent action. We also found that berberine increased the expression of MOR and DOR in the mouse bowel and rat fetal cortical neurons. Berberine significantly improved IBS-D symptoms in animal models, possibly through mu- and delta- opioid receptors. Berberine may become a new drug candidate for the successful treatment of IBS-D in clinical conditions.</description><subject>Analgesics</subject><subject>Animal models</subject><subject>Animals</subject><subject>Anticancer properties</subject><subject>Antidepressants</subject><subject>Antitumor activity</subject><subject>Berberine</subject><subject>Berberine - pharmacology</subject><subject>Care and treatment</subject><subject>Diarrhea</subject><subject>Diarrhea - complications</subject><subject>Diarrhea - drug therapy</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Fetuses</subject><subject>Gastrointestinal Motility - drug effects</subject><subject>Gastrointestinal tract</subject><subject>Health aspects</subject><subject>Hospitals</subject><subject>In vitro methods and tests</subject><subject>Inflammation</subject><subject>Intestinal motility</subject><subject>Intestine</subject><subject>Irritable bowel syndrome</subject><subject>Irritable Bowel Syndrome - complications</subject><subject>Irritable Bowel Syndrome - drug therapy</subject><subject>Laboratory animals</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mimicry</subject><subject>Motility</subject><subject>Narcotics</subject><subject>Neurons</subject><subject>Opioid receptors (type delta)</subject><subject>Opioid receptors (type mu)</subject><subject>Pain</subject><subject>Pain perception</subject><subject>Physiological effects</subject><subject>Physiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Receptors</subject><subject>Receptors, Opioid - genetics</subject><subject>Receptors, Opioid - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - genetics</subject><subject>Rodents</subject><subject>Secretion</subject><subject>Visceral Pain - drug therapy</subject><subject>Visceral Pain - etiology</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk9tu1DAQhiMEolB4AwSWkFB7kcWOHSe5QeqBQ6RWrVrorTWbTHZdEjvY3kLfjYfDoduqi3qBEiXR-Jt_MqckecXojPGCvb-0K2egn43W4Iwykee5fJQ8YxXPUplR_vje91by3PtLSnNeSvk02cpkQWkps2fJ7310c3TaIKmH0dkr9KQ2AX3QUZwc26B7Ha4JmJZcaN-gi9ZT0IbEOywxEis_PVvsPTnWg26-a7MghxqcWyKkpw5bO0QxE0jtnA4w75Hs25_Yk_Nr0zo7INmp98_Tw91oGMZgBz-JgyEno7a6Tc-wwWh25BBHNC1GpWMwBt2L5EkHvceX6_d28u3Tx68HX9Kjk8_1wd5R2sgqCymHcl5B3rASZF5wFFBx2XIGRVHEM6RNxjjNqkJAAQiCxdoUKDomJkBIvp28udEde-vVuvBesSJnosxEnkWiviFaC5dqdHoAd60saPXXYN1CgQu66VFRAdCVuaCNaISsaDUHKeYdSCyAZ3SK9mEdbTUfsG1ivrHoG6KbJ0Yv1cJeKSHLSpQ0CuysBZz9sYqtVMPUub4Hg7Fb039neSloWUX07T_ow9mtqQXEBLTpbIzbTKJqT_CS51RUZaRmD1DxajFORZzSTkf7hsPuhkNkAv4KC1h5r-rzs_9nTy422Xf32DiEfVh626-CtsZvguIGbJz13mF3V2RG1bRkt9VQ05Kp9ZJFt9f3G3TndLtV_A-INiK7</recordid><startdate>20151223</startdate><enddate>20151223</enddate><creator>Chen, Chunqiu</creator><creator>Lu, Meiling</creator><creator>Pan, Qiuhui</creator><creator>Fichna, Jakub</creator><creator>Zheng, Lijun</creator><creator>Wang, Kesheng</creator><creator>Yu, Zhen</creator><creator>Li, Yongyu</creator><creator>Li, Kun</creator><creator>Song, Aihong</creator><creator>Liu, Zhongchen</creator><creator>Song, Zhenshun</creator><creator>Kreis, Martin</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20151223</creationdate><title>Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner</title><author>Chen, Chunqiu ; Lu, Meiling ; Pan, Qiuhui ; Fichna, Jakub ; Zheng, Lijun ; Wang, Kesheng ; Yu, Zhen ; Li, Yongyu ; Li, Kun ; Song, Aihong ; Liu, Zhongchen ; Song, Zhenshun ; Kreis, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-3a8b9a5c18a6573e4a936d31a7773a8e0c21302974a7aea410087e4f147773463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Analgesics</topic><topic>Animal models</topic><topic>Animals</topic><topic>Anticancer properties</topic><topic>Antidepressants</topic><topic>Antitumor activity</topic><topic>Berberine</topic><topic>Berberine - pharmacology</topic><topic>Care and treatment</topic><topic>Diarrhea</topic><topic>Diarrhea - complications</topic><topic>Diarrhea - drug therapy</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Fetuses</topic><topic>Gastrointestinal Motility - drug effects</topic><topic>Gastrointestinal tract</topic><topic>Health aspects</topic><topic>Hospitals</topic><topic>In vitro methods and tests</topic><topic>Inflammation</topic><topic>Intestinal motility</topic><topic>Intestine</topic><topic>Irritable bowel syndrome</topic><topic>Irritable Bowel Syndrome - complications</topic><topic>Irritable Bowel Syndrome - drug therapy</topic><topic>Laboratory animals</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mimicry</topic><topic>Motility</topic><topic>Narcotics</topic><topic>Neurons</topic><topic>Opioid receptors (type delta)</topic><topic>Opioid receptors (type mu)</topic><topic>Pain</topic><topic>Pain perception</topic><topic>Physiological effects</topic><topic>Physiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Receptors</topic><topic>Receptors, Opioid - genetics</topic><topic>Receptors, Opioid - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - genetics</topic><topic>Rodents</topic><topic>Secretion</topic><topic>Visceral Pain - drug therapy</topic><topic>Visceral Pain - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Chunqiu</creatorcontrib><creatorcontrib>Lu, Meiling</creatorcontrib><creatorcontrib>Pan, Qiuhui</creatorcontrib><creatorcontrib>Fichna, Jakub</creatorcontrib><creatorcontrib>Zheng, Lijun</creatorcontrib><creatorcontrib>Wang, Kesheng</creatorcontrib><creatorcontrib>Yu, Zhen</creatorcontrib><creatorcontrib>Li, Yongyu</creatorcontrib><creatorcontrib>Li, Kun</creatorcontrib><creatorcontrib>Song, Aihong</creatorcontrib><creatorcontrib>Liu, Zhongchen</creatorcontrib><creatorcontrib>Song, Zhenshun</creatorcontrib><creatorcontrib>Kreis, Martin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Chunqiu</au><au>Lu, Meiling</au><au>Pan, Qiuhui</au><au>Fichna, Jakub</au><au>Zheng, Lijun</au><au>Wang, Kesheng</au><au>Yu, Zhen</au><au>Li, Yongyu</au><au>Li, Kun</au><au>Song, Aihong</au><au>Liu, Zhongchen</au><au>Song, Zhenshun</au><au>Kreis, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-12-23</date><risdate>2015</risdate><volume>10</volume><issue>12</issue><spage>e0145556</spage><epage>e0145556</epage><pages>e0145556-e0145556</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Berberine and its derivatives display potent analgesic, anti-inflammatory and anticancer activity. Here we aimed at characterizing the mechanism of action of berberine in the gastrointestinal (GI) tract and cortical neurons using animal models and in vitro tests. The effect of berberine was characterized in murine models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms. Then the opioid antagonists were used to identify the receptors involved. Furthermore, the effect of berberineon opioid receptors expression was established in the mouse intestine and rat fetal cortical neurons. In mouse models, berberine prolonged GI transit and time to diarrhea in a dose-dependent manner, and significantly reduced visceral pain. In physiological conditions the effects of berberine were mediated by mu- (MOR) and delta- (DOR) opioid receptors; hypermotility, excessive secretion and nociception were reversed by berberine through MOR and DOR-dependent action. We also found that berberine increased the expression of MOR and DOR in the mouse bowel and rat fetal cortical neurons. Berberine significantly improved IBS-D symptoms in animal models, possibly through mu- and delta- opioid receptors. Berberine may become a new drug candidate for the successful treatment of IBS-D in clinical conditions.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>26700862</pmid><doi>10.1371/journal.pone.0145556</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2015-12, Vol.10 (12), p.e0145556-e0145556
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1751482452
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Analgesics
Animal models
Animals
Anticancer properties
Antidepressants
Antitumor activity
Berberine
Berberine - pharmacology
Care and treatment
Diarrhea
Diarrhea - complications
Diarrhea - drug therapy
Disease Models, Animal
Female
Fetuses
Gastrointestinal Motility - drug effects
Gastrointestinal tract
Health aspects
Hospitals
In vitro methods and tests
Inflammation
Intestinal motility
Intestine
Irritable bowel syndrome
Irritable Bowel Syndrome - complications
Irritable Bowel Syndrome - drug therapy
Laboratory animals
Male
Medical research
Medicine
Mice
Mice, Inbred BALB C
Mimicry
Motility
Narcotics
Neurons
Opioid receptors (type delta)
Opioid receptors (type mu)
Pain
Pain perception
Physiological effects
Physiology
Rats
Rats, Sprague-Dawley
Real-Time Polymerase Chain Reaction
Receptors
Receptors, Opioid - genetics
Receptors, Opioid - metabolism
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - genetics
Rodents
Secretion
Visceral Pain - drug therapy
Visceral Pain - etiology
title Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T01%3A00%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Berberine%20Improves%20Intestinal%20Motility%20and%20Visceral%20Pain%20in%20the%20Mouse%20Models%20Mimicking%20Diarrhea-Predominant%20Irritable%20Bowel%20Syndrome%20(IBS-D)%20Symptoms%20in%20an%20Opioid-Receptor%20Dependent%20Manner&rft.jtitle=PloS%20one&rft.au=Chen,%20Chunqiu&rft.date=2015-12-23&rft.volume=10&rft.issue=12&rft.spage=e0145556&rft.epage=e0145556&rft.pages=e0145556-e0145556&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0145556&rft_dat=%3Cgale_plos_%3EA438350498%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1751482452&rft_id=info:pmid/26700862&rft_galeid=A438350498&rft_doaj_id=oai_doaj_org_article_04aaf8540c4c46909ba64bfa6e7a3206&rfr_iscdi=true